248 related articles for article (PubMed ID: 21205592)
1. Myocardial injury following coronary artery surgery versus angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging.
van Gaal WJ; Arnold JR; Testa L; Karamitsos T; Lim CC; Ponnuthurai FA; Petersen S; Francis JM; Selvanayagam J; Sayeed R; West N; Westaby S; Neubauer S; Banning AP
EuroIntervention; 2011 Jan; 6(6):703-10. PubMed ID: 21205592
[TBL] [Abstract][Full Text] [Related]
2. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.
Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Lima EG; Vieira RD; Garcia RM; Favarato D; Segre CA; Pereira AC; Soares PR; Ribeiro E; Lemos P; Perin MA; Strunz CC; Dallan LA; Jatene FB; Stolf NA; Hueb AC; Dias R; Gaiotto FA; da Costa LM; Oikawa FT; de Melo RM; Serrano CV; de Ávila LF; Villa AV; Filho JR; Nomura C; Ramires JA; Kalil Filho R;
BMC Cardiovasc Disord; 2012 Aug; 12():65. PubMed ID: 22898311
[TBL] [Abstract][Full Text] [Related]
3. Systemic levels of endothelin correlate with systemic inflammation and not with myocardial injury or left ventricular ejection fraction in patients undergoing percutaneous coronary intervention and on-pump coronary artery bypass grafting.
Cuculi F; Lim CC; van Gaal W; Testa L; Westaby S; Arnold JR; Neubauer S; Banning AP
Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):585-9. PubMed ID: 21908890
[TBL] [Abstract][Full Text] [Related]
4. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.
Lim CC; van Gaal WJ; Testa L; Cuculi F; Arnold JR; Karamitsos T; Francis JM; Petersen SE; Digby JE; Westaby S; Antoniades C; Kharbanda RK; Burrell LM; Neubauer S; Banning AP
J Am Coll Cardiol; 2011 Feb; 57(6):653-61. PubMed ID: 21292125
[TBL] [Abstract][Full Text] [Related]
5. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
[TBL] [Abstract][Full Text] [Related]
6. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
[TBL] [Abstract][Full Text] [Related]
7. Combined assessment of myocardial perfusion and late gadolinium enhancement in patients after percutaneous coronary intervention or bypass grafts: a multicenter study of an integrated cardiovascular magnetic resonance protocol.
Bernhardt P; Spiess J; Levenson B; Pilz G; Höfling B; Hombach V; Strohm O
JACC Cardiovasc Imaging; 2009 Nov; 2(11):1292-300. PubMed ID: 19909933
[TBL] [Abstract][Full Text] [Related]
8. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
JACC Cardiovasc Interv; 2010 Jun; 3(6):612-23. PubMed ID: 20630454
[TBL] [Abstract][Full Text] [Related]
9. Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting.
Barlis P; Horrigan M; Elis S; Chan R; Wong M; Farouque O; Proimos G; Ajani AE; Clark DJ
Cardiovasc Revasc Med; 2007; 8(2):84-9. PubMed ID: 17574165
[TBL] [Abstract][Full Text] [Related]
10. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
[TBL] [Abstract][Full Text] [Related]
11. Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
Vieira de Melo RM; Hueb W; Nomura CH; Ribeiro da Silva EE; Villa AV; Oikawa FTC; da Costa LMA; Rezende PC; Garzillo CL; Lima EG; Franchini Ramires JA; Kalil Filho R
Catheter Cardiovasc Interv; 2017 Jul; 90(1):87-93. PubMed ID: 28573785
[TBL] [Abstract][Full Text] [Related]
12. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
Fujii K; Kawasaki D; Oka K; Akahori H; Iwasaku T; Fukunaga M; Eguchi A; Sawada H; Masutani M; Lee-Kawabata M; Tsujino T; Ohyanagi M; Masuyama T
JACC Cardiovasc Interv; 2011 May; 4(5):513-20. PubMed ID: 21596324
[TBL] [Abstract][Full Text] [Related]
13. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis.
White AJ; Kedia G; Mirocha JM; Lee MS; Forrester JS; Morales WC; Dohad S; Kar S; Czer LS; Fontana GP; Trento A; Shah PK; Makkar RR
JACC Cardiovasc Interv; 2008 Jun; 1(3):236-45. PubMed ID: 19463306
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial.
Hueb W; Gersh BJ; Alves da Costa LM; Costa Oikawa FT; Vieira de Melo RM; Rezende PC; Garzillo CL; Lima EG; Nomura CH; Villa AV; Hueb AC; Cassaro Strunz CM; Favarato D; Takiuti ME; de Albuquerque CP; Ribeiro da Silva EE; Franchini Ramires JA; Kalil Filho R
Ann Thorac Surg; 2016 Jun; 101(6):2202-8. PubMed ID: 26912303
[TBL] [Abstract][Full Text] [Related]
15. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
[TBL] [Abstract][Full Text] [Related]
16. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
[TBL] [Abstract][Full Text] [Related]
17. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP;
JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656
[TBL] [Abstract][Full Text] [Related]
18. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
Serruys PW; Farooq V; Vranckx P; Girasis C; Brugaletta S; Garcia-Garcia HM; Holmes DR; Kappetein AP; Mack MJ; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Pereda P; Huang J; Morel MA; Van Es GA; Dawkins KD; Mohr FW; Steyerberg EW
JACC Cardiovasc Interv; 2012 Jun; 5(6):606-17. PubMed ID: 22721655
[TBL] [Abstract][Full Text] [Related]
19. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
[TBL] [Abstract][Full Text] [Related]
20. Assessment of left ventricle diastolic function in myocardial infarction patients treated with primary angioplasty.
Misztal M; Stopyra K; Gackowski A; Zmudka K; Piwowarska W
Cardiol J; 2009; 16(5):440-6. PubMed ID: 19753523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
